In conclusion, we have shown that inhibiting DNA methylation causes a switch in the relative levels of p63 isoforms, potentially converting ΔNp63-mediated tumor promotion and therapy resistance (7–9, 12, 13) towards TAp63-mediated tumor suppression (3, 4, 6, 10, 11). This evidence concerns the gene TP63 and neoplasm.